Teva Pharmaceutical Industries (NYSE:TEVA) earnings and shareholder returns have been trending downwards for the last five years, but the stock lifts 3.6% this past week
Teva Pharmaceutical: Generic Market Access to Global Healthcare Industry | IntechOpen